Related references
Note: Only part of the references are listed.Current insights into the metastasis of epithelial ovarian cancer-hopes and hurdles
Meysam Yousefi et al.
CELLULAR ONCOLOGY (2020)
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
Lauren C. Peres et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
Lauren C. Peres et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases
Yuan Cheng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
Tumor-associated macrophages: role in cancer development and therapeutic implications
Arash Salmaninejad et al.
CELLULAR ONCOLOGY (2019)
CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition
Yongning Lu et al.
CELL COMMUNICATION AND SIGNALING (2019)
Licofelone Enhances the Efficacy of Paclitaxel in Ovarian Cancer by Reversing Drug Resistance and Tumor Stem-like Properties
Jeff Hirst et al.
CANCER RESEARCH (2018)
Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistance
Pritish Nilendu et al.
CELLULAR ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas
Thing Rinda Soong et al.
JOURNAL OF PATHOLOGY (2018)
CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-kappa B/SOX4 signaling
Neng Wang et al.
CELL DEATH & DISEASE (2018)
Regulation of HGF and c-MET Interaction in Normal Ovary and Ovarian Cancer: Importance of Targeting c-MET and HGF Interaction
Youngjoo Kwon et al.
REPRODUCTIVE SCIENCES (2017)
Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)
Ursula A. Germann et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Effect of CCL2 siRNA on proliferation and apoptosis in the U251 human glioma cell line
Bin Lu et al.
MOLECULAR MEDICINE REPORTS (2017)
High grade serous ovarian carcinomas originate in the fallopian tube
S. Intidhar Labidi-Galy et al.
NATURE COMMUNICATIONS (2017)
Exosomes as mediators of platinum resistance in ovarian cancer
Jennifer Crow et al.
ONCOTARGET (2017)
CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer
Dingzhi Wang et al.
CANCER RESEARCH (2017)
Targeting tumor microenvironment in cancer therapy
Shree Ram Singh et al.
CANCER LETTERS (2016)
Elevated CXCL1 increases hepatocellular carcinoma aggressiveness and is inhibited by miRNA-200a
Xiao Cui et al.
ONCOTARGET (2016)
Chemokine CXCL1 may serve as a potential molecular target for hepatocellular carcinoma
Ke-qi Han et al.
CANCER MEDICINE (2016)
Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for Prevention
Sophia H. L. George et al.
FRONTIERS IN ONCOLOGY (2016)
Chemokine CXCL1 mediated neutrophil recruitment: Role of glycosaminoglycan interactions
Kirti V. Sawant et al.
SCIENTIFIC REPORTS (2016)
Chemokine CXCL1-Mediated Neutrophil Trafficking in the Lung: Role of CXCR2 Activation
Kirti V. Sawant et al.
JOURNAL OF INNATE IMMUNITY (2015)
Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis
Yu Sun et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2015)
Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment
Y. Kwon et al.
ONCOGENE (2015)
NF-κB and STAT1 control CXCL1 and CXCL2 gene transcription
Susan J. Burke et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins
An Zou et al.
BMC CANCER (2014)
The MAPK Pathway Across Different Malignancies: A New Perspective
Mauricio Burotto et al.
CANCER (2014)
Overexpression of Chemokine (C-X-C) ligand 1 (CXCL1) associated with tumor progression and poor prognosis in hepatocellular carcinoma
Zhongwei Cao et al.
CANCER CELL INTERNATIONAL (2014)
The role of the fallopian tube in the origin of ovarian cancer
Britt K. Erickson et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2013)
BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation
Britta Stordal et al.
MOLECULAR ONCOLOGY (2013)
Evaluating cell lines as tumour models by comparison of genomic profiles
Silvia Domcke et al.
NATURE COMMUNICATIONS (2013)
CXCL1/GROα increases cell migration and invasion of prostate cancer by decreasing fibulin-1 expression through NF-κB/HDAC1 epigenetic regulation
Po-Lin Kuo et al.
CARCINOGENESIS (2012)
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-Shifting the paradigm
Robert J. Kurman et al.
HUMAN PATHOLOGY (2011)
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Robert J. Kurman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
CXCR2 Promotes Ovarian Cancer Growth through Dysregulated Cell Cycle, Diminished Apoptosis, and Enhanced Angiogenesis
Gong Yang et al.
CLINICAL CANCER RESEARCH (2010)
The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor
Christine Bolitho et al.
ENDOCRINE-RELATED CANCER (2010)
BRCA-mutation-associated fallopian tube carcinoma - A distinct clinical phenotype?
R Cass et al.
OBSTETRICS AND GYNECOLOGY (2005)
Chemokines in innate and adaptive host defense: Basic chemokinese grammar for immune cells
A Rot et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Share Paper
